Report Detail
Global Glucagon Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
- RnM2974981 |
- 18 February, 2019 |
- Global |
- 124 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release sugar (glucose) into the bloodstream to bring the blood sugar level back up.
Scope of the Report:
The classification of glucagon includes inject glucagon and nasal glucagon, and now almost all the product is the type of injection. In 2018, Eli Lilly will launch the nasal glucagon in the market.
Glucagon is widely used in emergency kits, general use, diagnostic & motility, cardiogenic shock and other field. The most proportion of Glucagon is emergency kits, which is about 335 in2016.
North America is the largest consumption place, with a consumption market share nearly 41% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 25%.
Market competition is intense. Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The worldwide market for Glucagon is expected to grow at a CAGR of roughly 6.2% over the next five years, will reach 620 million US$ in 2024, from 430 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Glucagon in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Novo Nordisk
Eli Lilly
Fresenius Kabi
Torrent Labs
Taj Pharmaceuticals
Xeris Pharmaceuticals
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Inject Glucagon
Nasal Glucagon
Market Segment by Applications, can be divided into
Emergency Kits
General Use
Diagnostic & Motility
Cardiogenic Shock
Others
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Glucagon product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Glucagon, with price, sales, revenue and global market share of Glucagon in 2017 and 2018.
Chapter 3, the Glucagon competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Glucagon breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Glucagon market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Glucagon sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
- 1.1 Glucagon Introduction
- 1.2 Market Analysis by Type
- 1.2.1 Inject Glucagon
- 1.2.2 Nasal Glucagon
- 1.3 Market Analysis by Applications
- 1.3.1 Emergency Kits
- 1.3.2 General Use
- 1.3.3 Diagnostic & Motility
- 1.3.4 Cardiogenic Shock
- 1.3.5 Others
- 1.4 Market Analysis by Regions
- 1.4.1 North America (United States, Canada and Mexico)
- 1.4.1.1 United States Market States and Outlook (2014-2024)
- 1.4.1.2 Canada Market States and Outlook (2014-2024)
- 1.4.1.3 Mexico Market States and Outlook (2014-2024)
- 1.4.2 Europe (Germany, France, UK, Russia and Italy)
- 1.4.2.1 Germany Market States and Outlook (2014-2024)
- 1.4.2.2 France Market States and Outlook (2014-2024)
- 1.4.2.3 UK Market States and Outlook (2014-2024)
- 1.4.2.4 Russia Market States and Outlook (2014-2024)
- 1.4.2.5 Italy Market States and Outlook (2014-2024)
- 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- 1.4.3.1 China Market States and Outlook (2014-2024)
- 1.4.3.2 Japan Market States and Outlook (2014-2024)
- 1.4.3.3 Korea Market States and Outlook (2014-2024)
- 1.4.3.4 India Market States and Outlook (2014-2024)
- 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
- 1.4.4 South America, Middle East and Africa
- 1.4.4.1 Brazil Market States and Outlook (2014-2024)
- 1.4.4.2 Egypt Market States and Outlook (2014-2024)
- 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
- 1.4.4.4 South Africa Market States and Outlook (2014-2024)
- 1.4.4.5 Turkey Market States and Outlook (2014-2024)
- 1.4.1 North America (United States, Canada and Mexico)
- 1.5 Market Dynamics
- 1.5.1 Market Opportunities
- 1.5.2 Market Risk
- 1.5.3 Market Driving Force
2 Manufacturers Profiles
- 2.1 Novo Nordisk
- 2.1.1 Business Overview
- 2.1.2 Glucagon Type and Applications
- 2.1.2.1 Product A
- 2.1.2.2 Product B
- 2.1.3 Novo Nordisk Glucagon Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.2 Eli Lilly
- 2.2.1 Business Overview
- 2.2.2 Glucagon Type and Applications
- 2.2.2.1 Product A
- 2.2.2.2 Product B
- 2.2.3 Eli Lilly Glucagon Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.3 Fresenius Kabi
- 2.3.1 Business Overview
- 2.3.2 Glucagon Type and Applications
- 2.3.2.1 Product A
- 2.3.2.2 Product B
- 2.3.3 Fresenius Kabi Glucagon Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.4 Torrent Labs
- 2.4.1 Business Overview
- 2.4.2 Glucagon Type and Applications
- 2.4.2.1 Product A
- 2.4.2.2 Product B
- 2.4.3 Torrent Labs Glucagon Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.5 Taj Pharmaceuticals
- 2.5.1 Business Overview
- 2.5.2 Glucagon Type and Applications
- 2.5.2.1 Product A
- 2.5.2.2 Product B
- 2.5.3 Taj Pharmaceuticals Glucagon Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.6 Xeris Pharmaceuticals
- 2.6.1 Business Overview
- 2.6.2 Glucagon Type and Applications
- 2.6.2.1 Product A
- 2.6.2.2 Product B
- 2.6.3 Xeris Pharmaceuticals Glucagon Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Glucagon Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
- 3.1 Global Glucagon Sales and Market Share by Manufacturer (2017-2018)
- 3.2 Global Glucagon Revenue and Market Share by Manufacturer (2017-2018)
- 3.3 Market Concentration Rate
- 3.3.1 Top 3 Glucagon Manufacturer Market Share in 2018
- 3.3.2 Top 6 Glucagon Manufacturer Market Share in 2018
- 3.4 Market Competition Trend
4 Global Glucagon Market Analysis by Regions
- 4.1 Global Glucagon Sales, Revenue and Market Share by Regions
- 4.1.1 Global Glucagon Sales and Market Share by Regions (2014-2019)
- 4.1.2 Global Glucagon Revenue and Market Share by Regions (2014-2019)
- 4.2 North America Glucagon Sales and Growth Rate (2014-2019)
- 4.3 Europe Glucagon Sales and Growth Rate (2014-2019)
- 4.4 Asia-Pacific Glucagon Sales and Growth Rate (2014-2019)
- 4.5 South America Glucagon Sales and Growth Rate (2014-2019)
- 4.6 Middle East and Africa Glucagon Sales and Growth Rate (2014-2019)
5 North America Glucagon by Country
- 5.1 North America Glucagon Sales, Revenue and Market Share by Country
- 5.1.1 North America Glucagon Sales and Market Share by Country (2014-2019)
- 5.1.2 North America Glucagon Revenue and Market Share by Country (2014-2019)
- 5.2 United States Glucagon Sales and Growth Rate (2014-2019)
- 5.3 Canada Glucagon Sales and Growth Rate (2014-2019)
- 5.4 Mexico Glucagon Sales and Growth Rate (2014-2019)
6 Europe Glucagon by Country
- 6.1 Europe Glucagon Sales, Revenue and Market Share by Country
- 6.1.1 Europe Glucagon Sales and Market Share by Country (2014-2019)
- 6.1.2 Europe Glucagon Revenue and Market Share by Country (2014-2019)
- 6.2 Germany Glucagon Sales and Growth Rate (2014-2019)
- 6.3 UK Glucagon Sales and Growth Rate (2014-2019)
- 6.4 France Glucagon Sales and Growth Rate (2014-2019)
- 6.5 Russia Glucagon Sales and Growth Rate (2014-2019)
- 6.6 Italy Glucagon Sales and Growth Rate (2014-2019)
7 Asia-Pacific Glucagon by Country
- 7.1 Asia-Pacific Glucagon Sales, Revenue and Market Share by Country
- 7.1.1 Asia-Pacific Glucagon Sales and Market Share by Country (2014-2019)
- 7.1.2 Asia-Pacific Glucagon Revenue and Market Share by Country (2014-2019)
- 7.2 China Glucagon Sales and Growth Rate (2014-2019)
- 7.3 Japan Glucagon Sales and Growth Rate (2014-2019)
- 7.4 Korea Glucagon Sales and Growth Rate (2014-2019)
- 7.5 India Glucagon Sales and Growth Rate (2014-2019)
- 7.6 Southeast Asia Glucagon Sales and Growth Rate (2014-2019)
8 South America Glucagon by Country
- 8.1 South America Glucagon Sales, Revenue and Market Share by Country
- 8.1.1 South America Glucagon Sales and Market Share by Country (2014-2019)
- 8.1.2 South America Glucagon Revenue and Market Share by Country (2014-2019)
- 8.2 Brazil Glucagon Sales and Growth Rate (2014-2019)
- 8.3 Argentina Glucagon Sales and Growth Rate (2014-2019)
- 8.4 Colombia Glucagon Sales and Growth Rate (2014-2019)
9 Middle East and Africa Glucagon by Countries
- 9.1 Middle East and Africa Glucagon Sales, Revenue and Market Share by Country
- 9.1.1 Middle East and Africa Glucagon Sales and Market Share by Country (2014-2019)
- 9.1.2 Middle East and Africa Glucagon Revenue and Market Share by Country (2014-2019)
- 9.2 Saudi Arabia Glucagon Sales and Growth Rate (2014-2019)
- 9.3 Turkey Glucagon Sales and Growth Rate (2014-2019)
- 9.4 Egypt Glucagon Sales and Growth Rate (2014-2019)
- 9.5 Nigeria Glucagon Sales and Growth Rate (2014-2019)
- 9.6 South Africa Glucagon Sales and Growth Rate (2014-2019)
10 Global Glucagon Market Segment by Type
- 10.1 Global Glucagon Sales, Revenue and Market Share by Type (2014-2019)
- 10.1.1 Global Glucagon Sales and Market Share by Type (2014-2019)
- 10.1.2 Global Glucagon Revenue and Market Share by Type (2014-2019)
- 10.2 Inject Glucagon Sales Growth and Price
- 10.2.1 Global Inject Glucagon Sales Growth (2014-2019)
- 10.2.2 Global Inject Glucagon Price (2014-2019)
- 10.3 Nasal Glucagon Sales Growth and Price
- 10.3.1 Global Nasal Glucagon Sales Growth (2014-2019)
- 10.3.2 Global Nasal Glucagon Price (2014-2019)
11 Global Glucagon Market Segment by Application
- 11.1 Global Glucagon Sales Market Share by Application (2014-2019)
- 11.2 Emergency Kits Sales Growth (2014-2019)
- 11.3 General Use Sales Growth (2014-2019)
- 11.4 Diagnostic & Motility Sales Growth (2014-2019)
- 11.5 Cardiogenic Shock Sales Growth (2014-2019)
- 11.6 Others Sales Growth (2014-2019)
12 Glucagon Market Forecast (2019-2024)
- 12.1 Global Glucagon Sales, Revenue and Growth Rate (2019-2024)
- 12.2 Glucagon Market Forecast by Regions (2019-2024)
- 12.2.1 North America Glucagon Market Forecast (2019-2024)
- 12.2.2 Europe Glucagon Market Forecast (2019-2024)
- 12.2.3 Asia-Pacific Glucagon Market Forecast (2019-2024)
- 12.2.4 South America Glucagon Market Forecast (2019-2024)
- 12.2.5 Middle East and Africa Glucagon Market Forecast (2019-2024)
- 12.3 Glucagon Market Forecast by Type (2019-2024)
- 12.3.1 Global Glucagon Sales Forecast by Type (2019-2024)
- 12.3.2 Global Glucagon Market Share Forecast by Type (2019-2024)
- 12.4 Glucagon Market Forecast by Application (2019-2024)
- 12.4.1 Global Glucagon Sales Forecast by Application (2019-2024)
- 12.4.2 Global Glucagon Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
- 13.1 Sales Channel
- 13.1.1 Direct Marketing
- 13.1.2 Indirect Marketing
- 13.1.3 Marketing Channel Future Trend
- 13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
- 15.1 Methodology
Summary:
Get latest Market Research Reports on Glucagon . Industry analysis & Market Report on Glucagon is a syndicated market report, published as Global Glucagon Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Glucagon market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
